Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vivani Medical, Inc.EYES · Entity 6636 | Chief Commercial Officer | February 19, 2019 | February 22, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vivani Medical, Inc.
Report date February 19, 2019 · Filed February 22, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option(right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.74 · Expires 2029-02-19 | Direct | 95,000 |
Reported balance
After 2019-02-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-02-19 · Grant · Acquired 95,000 · Balance 95,000 F1: The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date. |
| Restricted Stock Units(RSUs)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 48,000 |
Reported balance
After 2019-02-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-02-19 · Grant · Acquired 48,000 · Balance 48,000 F2: The RSUs will vest over four years, in equal annual installments, subject to continuous employment. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date.
F2: The RSUs will vest over four years, in equal annual installments, subject to continuous employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2019 Filed Feb 22, 2019 00:28 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantRestricted Stock Units(RSUs) · Derivative | 48,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012301 · doc4.xml · derivative · entry 2 OKLAND STEPHEN D · CIK 0001261287 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires not disclosed F2 · derivative.exercise_date: The RSUs will vest over four years, in equal annual installments, subject to continuous employment. F2 · derivative.expiration_date: The RSUs will vest over four years, in equal annual installments, subject to continuous employment. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:28 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option(right to buy) · Derivative | 95,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-19-012301 · doc4.xml · derivative · entry 1 OKLAND STEPHEN D · CIK 0001261287 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2029-02-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 13:30 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 7,764 | $1.03 | $7,989.16 |
DisclosureSEC source: 0001437749-18-021520 · rdgdoc.xml · nonDerivative · entry 2 OKLAND STEPHEN D · CIK 0001261287 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,641 Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 13:30 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 7,764 | $0.92 | $7,127.35 |
DisclosureSEC source: 0001437749-18-021520 · rdgdoc.xml · nonDerivative · entry 1 OKLAND STEPHEN D · CIK 0001261287 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,315 F1 · shares: Shares acquired under the 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| June 01, 2018 Filed Jun 2, 2018 00:29 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 7,435 | $1.96 | $14,587.47 |
DisclosureSEC source: 0001437749-18-011114 · rdgdoc.xml · nonDerivative · entry 2 OKLAND STEPHEN D · CIK 0001261287 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,641 Read SEC document |
| May 31, 2018 Filed Jun 2, 2018 00:29 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 7,435 | $1.16 | $8,594.86 |
DisclosureSEC source: 0001437749-18-011114 · rdgdoc.xml · nonDerivative · entry 1 OKLAND STEPHEN D · CIK 0001261287 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,076 F1 · shares: Shares acquired under the 2015 Employee Stock Purchase Plan (ESPP) Read SEC document |
| May 16, 2018 Filed May 18, 2018 22:12 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001615774-18-004095 · s109479_form4.xml · derivative · entry 1 OKLAND STEPHEN D · CIK 0001261287 · Commercial V.P, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-05-16 F2 · price: Not Applicable F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of May 16, 2018 (the "Vesting Commencement Date") and 6.25% of the total number of shares shall vest each quarterly anniversary of the Vesting Commencement Date thereafter, subject to continuous employment, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 04, 2018 Filed Jan 9, 2018 00:30 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 140,000 | Not disclosed Strike: $2.06 | Not disclosed |
DisclosureSEC source: 0001615774-18-000192 · s108660_form4.xml · derivative · entry 2 OKLAND STEPHEN D · CIK 0001261287 · Commercial VP, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2028-01-04 F4 · price: Not Applicable F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 4, 2018 (the "Vesting Commencement Date") and 6.25% of the total number of shares shall vest each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:06 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 220,840 | Not disclosed Strike: $1.97 | Not disclosed |
DisclosureSEC source: 0001615774-17-000046 · s105061_form4.xml · derivative · entry 2 OKLAND STEPHEN D · CIK 0001261287 · Commercial VP, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,840 Underlying: Common Stock · 220,840 shares Expires 2027-01-03 F2 · shares: Options to purchase 220,840 shares of the Company's common stock were granted to Mr. Okland under the Company's 2011 Equity Incentive Plan. F4 · price: Not Applicable F3 · derivative.exercise_date: Options vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.